Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Pharmacological Research|December 16, 2021
Current and future therapeutic perspective in chronic heart failureAnnamaria Mascolo, Gabriella di Mauro, Donato Cappetta, et al.
Drug Safety|June 19, 2021
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in EudravigilanceAnnamaria Mascolo, Cristina Scavone, Carmen Ferrajolo, et al.
Frontiers in Pharmacology|November 29, 2023
Sodium-glucose cotransporter-2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysisAnnamaria Mascolo, Concetta Rafaniello, Gabriella di Mauro, et al.
Pharmaceuticals (Basel, Switzerland)|October 28, 2023
Retrospective Analysis of a Real-Life Use of Tixagevimab-Cilgavimab plus SARS-CoV-2 Antivirals for Treatment of COVID-19Nicolina Capoluongo, Annamaria Mascolo, Francesca Futura Bernardi, et al.
European Journal of Pharmacology|July 27, 2025
Real-world safety comparison of liraglutide and semaglutide in weight management: Insights from European pharmacovigilance dataRosanna Ruggiero, Miriam Longo, Annamaria Mascolo, et al.
Frontiers in Cardiovascular Medicine|October 10, 2022
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summaryAnnamaria Mascolo, Raffaella Di Napoli, Nunzia Balzano, et al.
European Journal of Heart Failure|November 22, 2017
Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort studyMaurizio Sessa, Annamaria Mascolo, Rikke Nørmark Mortensen, et al.
British Journal of Pharmacology|May 7, 2021
Therapeutic strategies to fight COVID-19: Which is the status artis?Cristina Scavone, Annamaria Mascolo, Concetta Rafaniello, et al.
Pageof 7